ArticleBMC cancer2026
Habitat analysis and other AI technologies for Ki-67 prediction in hepatocellular carcinoma: a multi-center study.
Article in BMC cancer, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
objectivesTo develop various artificial intelligence (AI) models including radiomics, deep transfer learning (DTL) and habitat analysis models, as well as a combined model, for the preoperative noninvasive prediction of Ki-67 expression in hepatocellular carcinoma (HCC). MATERIALS AND
methodsA retrospective analysis was performed on 433 patients with pathologically confirmed HCC from two institutions. According to the postoperative immunohistochemical Ki-67 expression levels, patients were divided into a high Ki-67 expression group (n = 320) and a low Ki-67 expression group (n = 113). They were further split into a training set (n = 349) and a test set (n = 84) in chronological order. Univariable and multivariable logistic regression analyses were conducted to identify independent predictors of Ki-67 expression. Feature extraction was performed from radiomics, DTL, and habitat analysis, followed by subsequent model construction. Subsequently, the extracted multiple features were combined with clinical variables to establish a combined model, and a multivariable logistic regression model was used to construct a nomogram for this combined model. The performance of different models was compared using the area under the receiver operating characteristic curve (AUC), along with other diagnostic metrics including sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV). Statistical comparisons were conducted to evaluate the differences in performance between the models.
resultsIn the test set, the AUC values of the clinical, radiomics, DTL, habitat analysis and combined models were 0.741(95% CI: 0.616-0.866), 0.754(95% CI: 0.633-0.875), 0.805(95% CI: 0.700-0.911), 0.814(95% CI: 0.712-0.917) and 0.819(95% CI: 0.719-0.920), respectively. Among all the models, the combined model achieved the highest AUC value, followed by the habitat analysis model, but there was no statistical significance between the two. In addition, the combined model had the highest accuracy (94.3%) and sensitivity (95.2%) in the training set, while the habitat analysis model showed the highest accuracy (86.9%) and sensitivity (91.4%) in the test set.
conclusionRadiomics, DTL and habitat analysis models based on Gd-EOB-DTPA-enhanced MRI are effective for preoperative noninvasive prediction of Ki-67 expression in HCC, and the combined model nomogram has potential clinical application value.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.